CD27 and myeloid sarcoma: Previous molecular and flow cytometry studies have shown that double‐negative (DN; CD27-, IgD-) B cells are abnormally elevated in MS and NMOSD patients with active forms of the disease, a finding that is in agreement with our results (47, 48).